AI helper
This is an invitation to offer (ITO) for a Pharmaceutical Header Standing Offer Arrangement (PHA) with Queensland Health. The tender is for pharmaceutical products classified under specific therapeutic classes: analgesia, poisoning toxicity, diagnostic agents, musculoskeletal system surgical preparations. Offers must be lodged electronically by Monday, 15 June 2026, at 2:00 PM AEST. Key evaluation criteria include clinical suitability, functionality, comparative cost, supply capability, supplier capability and experience, risk management, and commitment to economic, environmental, social, and sustainable objectives. Mandatory criteria include ASIC current company extract, insurances, quality assurance, adherence to the Queensland Government Supplier Code of Conduct, TGA certifications, and coloured artwork/images for all products. Suppliers are required to provide samples if requested, and these samples must correspond to the goods supplied under the PHA. Samples must be delivered to Loading Dock 1, 794 Boundary Road, Richlands, Queensland, ****, within 3 business days of the principal requesting them. The offer validity period is a minimum of 12 months. All clarifications or questions must be communicated in writing to the principal's contact person, Sharyn Waldock, via VendorPanel by the closing date for questions, 21 May 2026. Offers must be submitted electronically to the VendorPanel website. Additional documents required for submission include Part C ITO Response Schedules, Schedule A Response Schedules, Schedule B Pricing Response, and Schedule C Value Add (if applicable), along with supplier acknowledgements, certifications, and execution of the offer. The principal reserves the right to make changes to the invitation process and may negotiate with suppliers. Warranties regarding anticompetitive conduct, conflict of interest, criminal organisations, and accuracy of information are ongoing. Access and inspection of supplier premises and documentation may be required.
The bid notice states that offers must be lodged by Monday, 15 June 2026, at 2:00 PM AEST.
The bid notice states that warranties are ongoing and cover anticompetitive conduct, conflict of interest, criminal organisations, and accuracy of information.
The bid notice states that the principal is not evaluating offers on the sole criterion of price. The criteria include clinical suitability, functionality, comparative cost, ability to meet supply requirements, supplier capability, experience and past performance, risk management strategies, and commitment to economic, environmental, sustainable, and social objectives.
The bid notice states that mandatory criteria include ASIC current company extract, insurances, quality assurance as per AS/NZS ISO 9001:2016 or licence to wholesale or TGA licence to manufacture, adherence to the Queensland Government Supplier Code of Conduct, TGA certifications for all products, and coloured artwork/images for all products.
The bid notice states that as part of its offer, the supplier must provide samples if requested of the required goods, and any goods supplied under a SOA must correspond with the sample submitted with the offer.
